Literature DB >> 1442575

Reproducibility of stress redistribution thallium-201 SPECT quantitative indexes of hypoperfused myocardium secondary to coronary artery disease.

F M Prigent1, D S Berman, J Elashoff, A Rozanski, J Maddahi, J Friedman, J H Dwyer.   

Abstract

To determine the reproducibility of quantitative indexes of hypoperfused myocardium by exercise thallium-201 single-photon emission computed tomography, duplicate studies were performed in 16 stable patients within 1 month. Twenty-three other patients, with intervals up to 13 months between studies, were retrospectively identified from medical records. Symptoms, weight, heart rate achieved and peak systolic blood pressure during the 2 studies were similar. Maximal counts circumferential profiles' polar maps were generated and divided into 3 vascular territories. The hypoperfused myocardium was defined as the percent stress profile points below the normal level. The observed values were compared between the 2 studies for each patient. Defect size ranged from 0 to 73%. The concordance correlation coefficient (a measure of the closeness of the data points to the line of identity) and mean absolute deviation were 0.94 and 4.5%, respectively, when all patients were considered together, 0.93 and 3.2%, respectively in the reproducibility group, and 0.94 and 5.1%, respectively, in the retrospective group. Inter- and intraobserver reproducibility were also very high. For individual vessels, the concordance correlation coefficients were all > or = 0.89 and the mean absolute deviations between 3.7 and 9%. Thus, in stable patients with repeat thallium studies within a year, the percent hypoperfused myocardium is highly reproducible.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442575     DOI: 10.1016/0002-9149(92)90758-q

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

2.  Analysis of serial images: a challenge and an opportunity.

Authors:  Ami E Iskandrian; Ernest V Garcia; Tracy Faber
Journal:  J Nucl Cardiol       Date:  2007-10-29       Impact factor: 5.952

3.  Long-term effects of a multimodal behavioral intervention on myocardial perfusion--a randomized controlled trial.

Authors:  Christian Albus; Peter Theissen; Martin Hellmich; Reinhard Griebenow; Beate Wilhelm; Demet Aslim; Harald Schicha; Karl Köhle
Journal:  Int J Behav Med       Date:  2009-05-08

4.  Sustained reduction of exercise perfusion defect extent and severity with isosorbide mononitrate (Imdur) as demonstrated by means of technetium 99m sestamibi.

Authors:  H C Lewin; R Hachamovitch; A G Harris; C Williams; J Schmidt; M Harris; K Van Train; G Siligan; D S Berman
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

5.  Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy.

Authors:  D S Berman; X Kang; E F Schisterman; J Gerlach; P B Kavanagh; J S Areeda; T Sharir; S W Hayes; L J Shaw; H C Lewin; J D Friedman; R Miranda; G Germano
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

6.  Automatic and visual reproducibility of perfusion and function measures for myocardial perfusion SPECT.

Authors:  Yuan Xu; Sean Hayes; Iftikhar Ali; Terrence D Ruddy; R Glenn Wells; Daniel S Berman; Guido Germano; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2010-10-21       Impact factor: 5.952

7.  Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis.

Authors:  Daniel S Berman; Xingping Kang; Heidi Gransar; James Gerlach; John D Friedman; Sean W Hayes; Louise E J Thomson; Rory Hachamovitch; Leslee J Shaw; Piotr J Slomka; Ling De Yang; Guido Germano
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.